Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Canine cancer vaccine trial gets underway
“The vaccine may not be effective, but this is probably the only approach to this type of vaccine, so we feel we have to try it." Professor Stephen Johnston.
Study is the largest of its kind in the history of veterinary medicine

One of the largest clinical trials conducted to date for canine cancer is currently underway in the United States.

Researchers from the University of California, Colorado State University and the University of Wisconsin are participating in the Vaccination Against Canine Cancer Study (VACCS trial) to assess a new vaccine strategy for the prevention, rather than the treatment, of cancer in dogs.

Scientists hope that, if the vaccine works, it could provide important justification for exploring a similar approach in humans.

David Vail, a professor and board-certified oncologist at the University of Wisconsin–Madison School of Veterinary Medicine, said: “We’re testing a totally novel way of creating an anti-cancer immune response. The holy grail would be to prevent cancer as opposed to waiting for it to start and then treating it.”

The preventative cancer vaccine works similarly to how an influenza vaccine supports the body’s ability to fight flu. I.e., “to have the immune system primed such that if a cancer cell develops, it will attack,” said Vail.  

With over 800 dogs participating in the trial, the study is the largest of its kind conducted to date, and in the history of veterinary medicine.

Professor Stephen Johnston from Arizona State University, who developed the vaccine, said: “The vaccine may not be effective, but this is probably the only approach to this type of vaccine, so we feel we have to try it. The implications of success would be quite large — for dogs and people.”

The vaccine is designed to target some 30 abnormal proteins found on the surface of cancer cells. These proteins, which are the result of incorrectly-coded RNA, are generally only found in patients with cancer.

Scientists hope that by vaccinating healthy patients with these proteins, together with a substance that stimulates an immune response, the vaccine could serve as a universal defender against cancer by “turning on” the immune system.

The vaccine will target several cancers common to dogs, including lymphoma, osteosarcoma, hemangiosarcoma and mastocytomas.

Participating dogs must be aged between six and 10 years, with no previous history of cancer. The dogs will receive either a series of inoculations or a placebo and will live at home while being checked two-to-three times a year, for five years after enrolment.

Researchers have agreed to cover the costs associated with diagnostics and treatment of any cancers that dogs develop, whether or not they are receiving a vaccine or placebo.

Become a member or log in to add this story to your CPD history

Celebrity chefs urge public to get baking to support Cats Protection fundraiser

News Story 1
 In support of Cats Protection's Pawsome Afternoon Tea fundraiser, Masterchef winner Tim Anderson and Great British Bake Off star Kim-Joy have shared biscuit recipes to help keen bakers raise money for needy cats across April.

The celebrity chefs are both cat owners and have said that they hope this fundraiser will help to raise awareness of cats in need and the importance of adopting a cat, rather than buying one.

This is the fourth year Cats Protection has run its Pawsome Afternoon Tea campaign, which encourages people to hold tea parties, bake sales and fundraising events to help raise money for the charity.

To view the recipes and other fundraising resources please visit the Cats Protection website. 

Click here for more...
News Shorts
BEVA offering free membership to vet students

The British Equine Veterinary Association (BEVA) is offering free membership to veterinary students. As part of a new initiative with the aim of encouraging more veterinary professionals into equine practice.

According to BEVA, less than one in ten veterinary students choose to work in equine practice. The association hopes that this initiative will provide insight into the field and the benefits of a career in equine medicine.

Benefits of membership include:
▪ access to a network of nearly 3,000 members
▪ special student rates to attend BEVA Congress
▪ online access to BEVA's Equine Veterinary Education (EVE) journal
▪ free access to the association's online learning platform
▪ free access to BEVA's practical veterinary apps
▪ exclusive discounts on a range of things from cinema tickets to grocery shopping.

BEVA will be releasing a series of short videos over the next few months from BEVA Council members, explaining what inspired them to work in equine practice.

Image (c) BEVA.